Global healthcare communications firm Real Chemistry has acquired Singapore-based Spurwing Communications, marking the launch of its first strategic Asia-Pacific hub as it expands its presence across the region.The acquisition strengthens Real Chemistry's footprint in APAC, a market the company says is becoming increasingly important for healthcare innovation and access to new therapies. The combined business aims to deliver more integrated, data-driven and locally relevant communications services to healthcare clients across the region.Kath Harrison, Group President, International Growth at Real Chemistry, said the deal would enhance the company's ability to help clients create measurable business impact through connected engagement strategies tailored to diverse APAC markets.Founded in Singapore, Spurwing Communications has worked with pharmaceutical companies, healthcare organisations and multinational brands throughout the Asia-Pacific region. Following the acquisition, founder-CEO Emma Thompson will continue to lead the business in the newly created role of President, APAC Growth, reporting to Harrison.Thompson said joining Real Chemistry would allow the agency to broaden its services while retaining its regional expertise and senior advisory approach. She added that the company plans to expand its APAC operations and introduce additional capabilities, including analytics and artificial intelligence, while continuing to support existing clients.Real Chemistry CEO Shankar Narayanan described the acquisition as a key milestone in the company's global growth strategy. He said expanding in APAC would strengthen the firm's ability to support clients across the full commercialisation journey, from strategic planning to stakeholder engagement, in one of the world's fastest-growing healthcare markets.